Oestradiol is the primary form of oestrogen in the body. It plays a central role in reproductive function, menstrual cycle regulation, bone maintenance, and cardiovascular health. In women, oestradiol levels fluctuate across the menstrual cycle and decline significantly after menopause. In men, small amounts of oestradiol are produced and contribute to bone density and reproductive function.
Standard immunoassay methods for measuring oestradiol work well when levels are moderate to high, such as in premenopausal women during the follicular and ovulatory phases. However, at low concentrations, immunoassay can produce inaccurate results due to cross-reactivity with other molecules in the blood. This is where the LC-MS/MS (liquid chromatography tandem mass spectrometry) method becomes relevant.
LC-MS/MS identifies oestradiol by its molecular structure rather than by antibody binding, which eliminates the cross-reactivity problem. The result is a more reliable measurement when oestradiol is expected to be low. This makes it the preferred method for men, post-menopausal women, children, and anyone on low-dose oestrogen therapy where precise measurement matters.
For men using testosterone replacement therapy or performance-related hormone protocols, accurate oestradiol monitoring is particularly important. Elevated oestradiol in the context of testosterone use can contribute to symptoms such as gynaecomastia, fluid retention, and mood changes. Standard immunoassay may overestimate oestradiol in men with high testosterone levels, making the LCMS method more appropriate.
If you are a premenopausal woman with normal to high oestradiol levels, the standard oestradiol blood test is usually sufficient. The LCMS version is specifically suited to situations where accuracy at the low end of the measurement range is needed.
Suited to men requiring accurate oestradiol measurement, post-menopausal women monitoring oestrogen status or hormone replacement therapy, paediatric investigations, and anyone where a standard immunoassay has produced results that seem inconsistent with symptoms. Also used when monitoring very low-dose oestrogen therapy.
